We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Arch Capital
ACGL
$33.4B
| $609K | ﹤0.01% |
29,655
-735,660
| -96% | -$14.7M |
|
|
KNL
802
DELISTED
Knoll, Inc.
KNL
| $609K | ﹤0.01% |
+25,987
| New | +$540K |
|
|
DMC
803
Del Monte Corp
DMC
$1.41B
| $608K | ﹤0.01% |
15,637
-72,055
| -82% | -$2.52M |
|
|
NWLIA
804
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $604K | ﹤0.01% |
2,374
| – | – |
|
805
Sociedad Química y Minera de Chile
SQM
$20.8B
| $599K | ﹤0.01% |
33,686
-38,431
| -53% | -$878K |
|
|
PGN
806
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $596K | ﹤0.01% |
458,364
-585,845
| -56% | -$1.23M |
|
|
THOR
807
DELISTED
THORATEC CORPORATION
THOR
| $583K | ﹤0.01% |
+13,906
| New | +$531K |
|
|
AV
808
DELISTED
Aviva Plc
AV
| $575K | ﹤0.01% |
+35,535
| New | +$577K |
|
809
TTM Technologies
TTMI
$14B
| $574K | ﹤0.01% |
+63,753
| New | +$524K |
|
810
Cohu
COHU
$2.41B
| $562K | ﹤0.01% |
+51,328
| New | +$581K |
|
811
1-800-Flowers.com
FLWS
$252M
| $562K | ﹤0.01% |
+47,524
| New | +$484K |
|
|
TRNX
812
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $560K | ﹤0.01% |
21,347
-33,319
| -61% | -$844K |
|
813
Entergy
ETR
$49.3B
| $558K | ﹤0.01% |
14,400
+5,610
| +64% | +$230K |
|
814
lululemon athletica
LULU
$14.4B
| $557K | ﹤0.01% |
+8,700
| New | +$558K |
|
|
STB
815
DELISTED
Student Transportation Inc
STB
| $556K | ﹤0.01% |
102,732
-42,979
| -29% | -$246K |
|
816
McKesson
MCK
$103B
| $543K | ﹤0.01% |
2,399
-62,095
| -96% | -$13.8M |
|
817
Conagra Brands
CAG
$7.13B
| $541K | ﹤0.01% |
19,018
-104,518
| -85% | -$2.88M |
|
818
Unitil
UTL
$969M
| $541K | ﹤0.01% |
15,559
-7,059
| -31% | -$249K |
|
|
LOGM
819
DELISTED
LogMein, Inc.
LOGM
| $538K | ﹤0.01% |
+9,600
| New | +$491K |
|
|
BCR
820
DELISTED
CR Bard Inc.
BCR
| $536K | ﹤0.01% |
3,200
-66,548
| -95% | -$11.4M |
|
821
Unisys
UIS
$216M
| $534K | ﹤0.01% |
22,986
-22,096
| -49% | -$538K |
|
822
Teck Resources
TECK
$33.1B
| $530K | ﹤0.01% |
38,646
-396,977
| -91% | -$5.59M |
|
823
Essent Group
ESNT
$6.26B
| $528K | ﹤0.01% |
22,088
+10,132
| +85% | +$243K |
|
824
Newmont
NEM
$122B
| $528K | ﹤0.01% |
+24,300
| New | +$568K |
|
|
HUB.B
825
DELISTED
HUBBELL INC CL-B
HUB.B
| $526K | ﹤0.01% |
4,800
-32,452
| -87% | -$3.56M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.